Ramshani, Zeinab
Zhang, Chenguang https://orcid.org/0000-0001-5124-875X
Richards, Katherine
Chen, Lulu https://orcid.org/0000-0003-0167-4632
Xu, Geyang
Stiles, Bangyan L.
Hill, Reginald
Senapati, Satyajyoti
Go, David B. https://orcid.org/0000-0001-8948-1442
Chang, Hsueh-Chia
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R21-HG009010-01)
Article History
Received: 19 December 2018
Accepted: 23 April 2019
First Online: 20 May 2019
Competing interests
: The authors declare no competing nonfinancial interests but do declare the following competing financial interests. Both S.S. and H.-C.C. hold some stock in AgenDx Biosciences Inc., a startup biotechnology company that has licensed some parts of the proposed integrated platform. S.S. and R.H. also serve as Scientific Consultants for AgenDx Biosciences Inc. and receive a consulting fee.